<DOC>
	<DOCNO>NCT02834624</DOCNO>
	<brief_summary>Premature infant frequently trouble breathe birth . If respiratory disorder cause surfactant deficiency dysfunction , disease treat medication call surfactant give infant tube insert windpipe . This study compare safety two commonly use surfactant , poractant calfactant , United States . Poractant add chemical call phospholipid know cause inflammation irritation body premature infant . The investigator compare another similar surfactant contain chemical look sample windpipe , tube place , blood test first day life . The investigator hop learn whether calfactant safer therapeutic agent treat respiratory distress syndrome preterm infant compare poractant .</brief_summary>
	<brief_title>Comparison Curosurf Infasurf Treatment Preterm Infants With Respiratory Distress Syndrome</brief_title>
	<detailed_description>30 infant randomize receive either poractant calfactant Respiratory Distress Syndrome . Tracheal aspirate obtain look increase macrophage blood sample draw look marker inflammation .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Calfactant</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Enrolled prior delivery sign informed consent HIPAA parent Gestational age le 35 week No maternal chorioamnionitis maternal fetal infection RDS determine attend neonatologist need treat exogenous surfactant mechanical ventilation Major Birth Defect , Malformation Syndrome Chromosomal Inherited Metabolic Disorder Proven Presence Immunodeficiency Antenatal exposure illicit substance ( e.g. , methamphetamine , cocaine , etc. , marijuana ) Birth Asphyxia ( cord pH &lt; 7.0 , Apgar score 3 less 10 minute age ) HIV congenital viral , bacterial fungal infection Lack Parental consent refusal attend neonatologist allow participation Discretion investigator The legal representative infant patient 's primary physician commit provide full , aggressive life support</criteria>
	<gender>All</gender>
	<minimum_age>22 Weeks</minimum_age>
	<maximum_age>35 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>surfactant</keyword>
	<keyword>respiratory distress syndrome</keyword>
	<keyword>inflammation</keyword>
	<keyword>c-reactive protein</keyword>
	<keyword>lipid peroxidation</keyword>
</DOC>